Hemolytic-Uremic Syndrome and Acute Renal Failure in Metastatic Adenocarcinoma Treated with Mitomycin: Case Report and Literature Review

References

• Brain M C, Azzopardi J G, Baker L RI, Pineo G F, Roberts P D, Dacie JV. Microangiopathic haemolytic anemia and mucin-forming adenocarcinoma. Br, J Haematol 1970; 18: 183–193
   PubMed Web of Science ®Google Scholar
• Liu K, Mittleman A, Sproul E E, Elias EG. Renal toxicity in man treated with mitomycin C. Cancer 1971; 28: 1314–1320
   PubMed Web of Science ®Google Scholar
• Heptinstall. Pathology of the Kidney3rd Ed. Little Brown 1983; Vol 2: 907–953
   Google Scholar
• Robbins H, Cotran R. Pathologic Basis of Disease. Saunders. 1984; 601–602
   Google Scholar
• Marcus O O, Escuin F, Miguel J L, Fernandez P G, Fontan M P, Selgas R, Sicilia LS. Hemolytic-uremic syndrome in a patient with gastric adenocarcinoma: partial recovery of renal function after gastrectomy. Clin Nephrol 1985; 24: 265–268
   Google Scholar
• Laffay D L, Tubbs R R, Valenzuela R, Hall P M, McCormack LJ. Chronic glomerular microangiopathy and metastatic carcinoma. Human Pathol 1979; 10: 433–437
   Google Scholar
• Desablens A, Fievet P, Pruna A, Claisse J F, Westeel P F, Tolani M, Fournier A. Hemolytic-uremic syndrome after cancer chemotherapy without Mitomycin C. Nephron 1986; 42: 343–344
   PubMed Web of Science ®Google Scholar
• Jackson A M, Rose B D, Graff L G, Jacobs J B, Schwartz J H, Strauss G M, Yang J PS, Rudnick M R, Elfenbein I B, Narins RG. Thrombotic microangiopathy and renal failure associated with antineoplastic chemotherapy. Ann Intern Med 1984; 101: 41–44
   PubMed Web of Science ®Google Scholar
• Tuttle S E, Sharma H M, Bay W H, Hebert LA. Glomerular basement membrane splitting and microaneurism formation associated with nitrosourea therapy. Am J Nephrol 1985; 5: 388–394
   Google Scholar
• Harrell R M, Sibley R, Voelzang NJ. Renal vascular lesions after chemotherapy with vinblastine, bleomycin, cisplatin. Am J Med 1982; 73: 429–433
   PubMed Web of Science ®Google Scholar
• Rabadi S J, Kanekar J D, Miller HJ. Mitomycin-induced hemolytic-uremic syndrome: presentation and review of literature. Cancer Treat Rep 1982; 66: 1244–1247
   PubMedGoogle Scholar
• Harden E, Lucas V S, Proia A, Silberman HR. Hemolytic-uremic syndrome during therapy with mitomycin C plus 5-fluorouracil. Am Soc Clin Oncol Abstr 1982; C-360
   Google Scholar
• Pavy M D, Wiley E L, Abeloff MD. Hemolytic-uremic syndrome associated with Mitomycin therapy. Cancer Treat 1982; 66: 467–471
   Google Scholar
• Cantrell J E, Phillips T M, Schein PS. Carcinoma-associated hemolytic-uremic syndrome: a complication of mitomycin C chemotherapy. J Clin Oncol 1985; 3: 723–734
   PubMed Web of Science ®Google Scholar
• Crocker J, Jones EL. Haemolytic-uraemic syndrome complicating long term Mitomycin C and 5-flourouracil therapy for gastric carcinoma. J Clin Pathol 1983; 36: 24–29
   Google Scholar
• Hamner R W, Verani R, Weinman EI. Mitomycin-associated renal failure. Arch Intern Med 1983; 143: 803–807
   PubMedGoogle Scholar
• Price T M, Murgo A J, Keveney J J, Miller-Hardy D, Kasprisin DO. Renal failure and hemolytic anemia associated with mitomycin C. Cancer 1985; 55: 51–56
   Google Scholar
• Lyman N W, Michaelson R, Viscuso R L, Winn R, Mulgaonkar S, Jacbos MG. Mitomycin-induced hemolytic-uremic syndrome. Arch Intern Med 1983; 143: 1617–1618
   PubMedGoogle Scholar
• Giroux L, Bettez P, Giroux L. Mitomycin C Nephrotoxicity: a clinico-pathologic study of 17 cases. Am J Kid Dis 1985; 6: 28–39
   PubMed Web of Science ®Google Scholar
• Grem J L, Merritt J A, Carbone PP. Treatment of mitomycin-associated microangiopathic hemolytic anemia with vincristine. Arch Intern Med 1986; 146: 566–568
   Google Scholar
• Hanna W T, Krauss S, Regester R F, Murphy WM. Renal disease after mitomycin C therapy. Cancer 1981; 48: 2583–2588
   PubMed Web of Science ®Google Scholar
• Gulati S C, Sordillo P, Kempin S, Reich L, Magiugg Scheiner E, Clarkson B. Microangiopathic hemolytic anemia observed after treatment of epidermoid carcinoma with mitomycin and 5-fluorouracil. Cancer 1980; 45: 2252–2257
   PubMed Web of Science ®Google Scholar
• Chow S, Roscoe J, Cattran DC. Plasmapheresis and antiplatlet agents in the treatment of the hemocytic uremic syndrone secondary to mitomycin. Am Kid Dis 1986; 7: 407–412
   PubMedGoogle Scholar
• Veronesi G, Vercellone A. Microangiopathic hemolytic anemia and postpartum acute renal failure. Nephron 1986; 44: 253–255
   Google Scholar
• Nand S, Bansal V K, Kozeny G, Vertuno L, Remlinger K A, Jordan JV, Jr. Red cell fragmentation syndrome with the use of subclavian hemodialysis catheters. Arch Intern Med 1985; 145: 1421–1423
   Google Scholar
• Rao S X, Ramaswamy G, Levin M, McCravey JW. Fatal acute respiratory failure after vinblastine-mitomycin therapy in lung carcinoma. Arch Intern Med 1985; 145: 1905–1907
   Google Scholar
• Barst R J, Ratner ST. Sarcoidosis and reactive pulmonary hypertension. Arch Intern Med 1985; 145: 2112–2114
   PubMedGoogle Scholar
• Monnens L, Vande Meer W, Langenhuysen C, Van Munster P, VanOostrom C. Platelet aggregating factor in the epidemic form of hemolytic-uremic syndrome in childhood. Clin Nephrol 1985; 24: 135–137
   Google Scholar
• Webster J, Rees P J, Lewis P J, Hensby CN. Prostacyclin deficiency in haemolytic uraemic syndrome. Br Med J 1980; 1: 27
   Google Scholar
• Sommer B G, Innes J T, Whitehurst R M, Sharma H M, Ferguson RM. Cyclosporine-associated renal arteriopathy resulting in loss of allograft function. Am J Surg 1985; 149: 756–764
   PubMed Web of Science ®Google Scholar
• Neild G H, Rocchi G, Imberti L, Fumagalli F, Brown Z, Remuz-Zi G, Williams DG. Effect of cyclosporin A on prostacyclin synthesis by vascular tissue. Thrombosis Res 1983; 32: 373–379
   PubMed Web of Science ®Google Scholar
• Remuzzi G, Marchesi D, Mecca G, Misiani R, Lirio M, DeGaetano G. Haemolytic-uraemic syndrome: deficiency of plasma factor(s) regulating prostacyclin activity?. Lancet 1978; 2: 871–872
   Google Scholar
• Wolfe J A, McCann R L, Sanfilippo F. Cyclosporine-associated microangiopathy in renal transplantation. Transplantation 1986; 41: 541–543
   PubMed Web of Science ®Google Scholar
• Keusch G, Gmur J, Baumgartner D, Burger H R, Largiader F, Binswanger V. De novo hemolytic uremic syndrome in two renal allograft recipients treated with cyclosporin: successful therapy with plasmaphersis. Kid Int 1986; 30: 457
   Google Scholar
• Bertani R, Rocchi G, Sacchi G, Mecca G, Remuzzi G. Adriamycin-induced glomerulosclerosis in the rat. Am J Kid Dis 1986; 7: 12–19
   PubMed Web of Science ®Google Scholar